Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
12001
12002
12003
12004
12005
12006
12007
12008
12009
12010
12011
12012
12013
12014
12015
12016
12017
12018
12019
12020
12021
12022
12023
12024
12025
12026
12027
12028
12029
12030
12031
12032
12033
12034
12035
12036
12037
12038
12039
12040
12041
12042
12043
12044
12045
12046
12047
12048
12049
12050
12051
12052
12053
12054
12055
12056
12057
12058
12059
12060
12061
12062
12063
12064
12065
12066
12067
12068
12069
12070
12071
12072
12073
12074
12075
12076
12077
12078
12079
12080
12081
12082
12083
12084
12085
12086
12087
12088
12089
12090
12091
12092
12093
12094
12095
12096
12097
12098
12099
12100
12101
12102
12103
12104
12105
12106
12107
12108
12109
12110
12111
12112
12113
12114
12115
12116
12117
12118
12119
12120
12121
12122
12123
12124
12125
12126
12127
12128
12129
12130
12131
12132
12133
12134
12135
12136
12137
12138
12139
12140
12141
12142
12143
12144
12145
12146
12147
12148
12149
12150
12151
12152
12153
12154
12155
12156
12157
12158
12159
12160
12161
12162
12163
12164
12165
12166
12167
12168
12169
12170
12171
12172
12173
12174
12175
12176
12177
12178
12179
12180
12181
12182
12183
12184
12185
12186
12187
12188
12189
12190
12191
12192
12193
12194
12195
12196
12197
12198
12199
12200
| UnnamedSample_HQ_transcript/22124|m.7464 | UnnamedSample_HQ_transcript/22124 | Coverage 0.310 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 427 | 459 | 8.7E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/22124|m.7464 | UnnamedSample_HQ_transcript/22124 | Coverage 0.310 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 467 | 496 | 5.9E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/22124|m.7464 | UnnamedSample_HQ_transcript/22124 | Coverage 0.310 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 505 | 534 | 5.9E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/22124|m.7464 | UnnamedSample_HQ_transcript/22124 | Coverage 0.310 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF07657 | N terminus of Notch ligand | 25 | 95 | 1.8E-23 | T | 22-09-2020 | IPR011651 | Notch ligand, N-terminal domain |
| UnnamedSample_HQ_transcript/33538|m.10343 | UnnamedSample_HQ_transcript/33538 | Coverage 0.191 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF01414 | Delta serrate ligand | 178 | 240 | 1.5E-21 | T | 22-09-2020 | IPR001774 | Delta/Serrate/lag-2 (DSL) protein |
| UnnamedSample_HQ_transcript/33538|m.10343 | UnnamedSample_HQ_transcript/33538 | Coverage 0.191 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 389 | 418 | 2.9E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/33538|m.10343 | UnnamedSample_HQ_transcript/33538 | Coverage 0.191 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 351 | 380 | 1.8E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/33538|m.10343 | UnnamedSample_HQ_transcript/33538 | Coverage 0.191 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 543 | 575 | 1.7E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/33538|m.10343 | UnnamedSample_HQ_transcript/33538 | Coverage 0.191 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 311 | 341 | 6.2E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/33538|m.10343 | UnnamedSample_HQ_transcript/33538 | Coverage 0.191 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 427 | 459 | 8.7E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/33538|m.10343 | UnnamedSample_HQ_transcript/33538 | Coverage 0.191 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 467 | 496 | 5.9E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/33538|m.10343 | UnnamedSample_HQ_transcript/33538 | Coverage 0.191 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 505 | 534 | 5.9E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/33538|m.10343 | UnnamedSample_HQ_transcript/33538 | Coverage 0.191 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF07657 | N terminus of Notch ligand | 25 | 95 | 1.8E-23 | T | 22-09-2020 | IPR011651 | Notch ligand, N-terminal domain |
| UnnamedSample_HQ_transcript/24726|m.8141 | UnnamedSample_HQ_transcript/24726 | Coverage 0.283 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF01414 | Delta serrate ligand | 178 | 240 | 1.5E-21 | T | 22-09-2020 | IPR001774 | Delta/Serrate/lag-2 (DSL) protein |
| UnnamedSample_HQ_transcript/24726|m.8141 | UnnamedSample_HQ_transcript/24726 | Coverage 0.283 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 389 | 418 | 2.9E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/24726|m.8141 | UnnamedSample_HQ_transcript/24726 | Coverage 0.283 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 351 | 380 | 1.8E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/24726|m.8141 | UnnamedSample_HQ_transcript/24726 | Coverage 0.283 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 543 | 575 | 1.7E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/24726|m.8141 | UnnamedSample_HQ_transcript/24726 | Coverage 0.283 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 311 | 341 | 6.2E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/24726|m.8141 | UnnamedSample_HQ_transcript/24726 | Coverage 0.283 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 427 | 459 | 8.7E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/24726|m.8141 | UnnamedSample_HQ_transcript/24726 | Coverage 0.283 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 467 | 496 | 5.9E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/24726|m.8141 | UnnamedSample_HQ_transcript/24726 | Coverage 0.283 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 505 | 534 | 5.9E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/24726|m.8141 | UnnamedSample_HQ_transcript/24726 | Coverage 0.283 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF07657 | N terminus of Notch ligand | 25 | 95 | 1.8E-23 | T | 22-09-2020 | IPR011651 | Notch ligand, N-terminal domain |
| UnnamedSample_HQ_transcript/12092|m.4523 | UnnamedSample_HQ_transcript/12092 | Coverage 0.202 too low. | de5a9fda7d8c15e7b5c9b8c05ca4e483 | 1219 | Pfam | PF05029 | Timeless PAB domain | 1002 | 1082 | 7.0E-21 | T | 22-09-2020 | IPR007725 | Timeless, C-terminal |
| UnnamedSample_HQ_transcript/12092|m.4523 | UnnamedSample_HQ_transcript/12092 | Coverage 0.202 too low. | de5a9fda7d8c15e7b5c9b8c05ca4e483 | 1219 | Pfam | PF04821 | Timeless protein | 24 | 286 | 3.5E-68 | T | 22-09-2020 | IPR006906 | Timeless, N-terminal |
| UnnamedSample_HQ_transcript/50850|m.14214 | UnnamedSample_HQ_transcript/50850 | Coverage 0.845 too low. | 9ad06b9c442f3cb6bd56b386730ceb5d | 456 | Pfam | PF07690 | Major Facilitator Superfamily | 90 | 421 | 2.2E-38 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/8243|m.3271 | UnnamedSample_HQ_transcript/8243 | Identity 0.834 too low. | 5179812d7cf6aa8b47a7d92a0d3dbbe8 | 1296 | Pfam | PF01535 | PPR repeat | 1004 | 1026 | 0.025 | T | 22-09-2020 | IPR002885 | Pentatricopeptide repeat |
| UnnamedSample_HQ_transcript/8243|m.3271 | UnnamedSample_HQ_transcript/8243 | Identity 0.834 too low. | 5179812d7cf6aa8b47a7d92a0d3dbbe8 | 1296 | Pfam | PF13812 | Pentatricopeptide repeat domain | 28 | 83 | 2.3E-8 | T | 22-09-2020 | IPR002885 | Pentatricopeptide repeat |
| UnnamedSample_HQ_transcript/8243|m.3271 | UnnamedSample_HQ_transcript/8243 | Identity 0.834 too low. | 5179812d7cf6aa8b47a7d92a0d3dbbe8 | 1296 | Pfam | PF13041 | PPR repeat family | 107 | 153 | 1.0E-7 | T | 22-09-2020 | IPR002885 | Pentatricopeptide repeat |
| UnnamedSample_HQ_transcript/110015|m.23834 | UnnamedSample_HQ_transcript/110015 | Coverage 0.900 too low. | 884aace737cc96efcdb7cfe800a55863 | 177 | Pfam | PF10996 | Beta-Casp domain | 24 | 149 | 1.2E-20 | T | 22-09-2020 | IPR022712 | Beta-Casp domain |
| UnnamedSample_HQ_transcript/40593|m.11976 | UnnamedSample_HQ_transcript/40593 | Identity 0.534 too low. | 78becc74857ee7e1c11af8e374054670 | 340 | Pfam | PF00151 | Lipase | 107 | 293 | 3.1E-23 | T | 22-09-2020 | IPR013818 | Lipase/vitellogenin |
| UnnamedSample_HQ_transcript/40538|m.11968 | UnnamedSample_HQ_transcript/40538 | Identity 0.942 too low. | 18a469ea389030236d5989ad98479695 | 517 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 284 | 346 | 1.9E-17 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/40538|m.11968 | UnnamedSample_HQ_transcript/40538 | Identity 0.942 too low. | 18a469ea389030236d5989ad98479695 | 517 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 46 | 114 | 7.2E-13 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/40538|m.11968 | UnnamedSample_HQ_transcript/40538 | Identity 0.942 too low. | 18a469ea389030236d5989ad98479695 | 517 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 173 | 238 | 7.1E-13 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/40538|m.11968 | UnnamedSample_HQ_transcript/40538 | Identity 0.942 too low. | 18a469ea389030236d5989ad98479695 | 517 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 398 | 462 | 7.2E-19 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/50242|m.14071 | UnnamedSample_HQ_transcript/50242 | Coverage 0.917 too low. | d0055a785eb71fd2443c5b10d5f1a96b | 681 | Pfam | PF00226 | DnaJ domain | 620 | 657 | 1.8E-12 | T | 22-09-2020 | IPR001623 | DnaJ domain |
| UnnamedSample_HQ_transcript/50242|m.14071 | UnnamedSample_HQ_transcript/50242 | Coverage 0.917 too low. | d0055a785eb71fd2443c5b10d5f1a96b | 681 | Pfam | PF00012 | Hsp70 protein | 5 | 607 | 2.0E-217 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/53018|m.14648 | UnnamedSample_HQ_transcript/53018 | Coverage 0.840 too low. | 66858fcbbe8c6664b82c85b37f1fbbef | 501 | Pfam | PF13520 | Amino acid permease | 39 | 433 | 1.2E-49 | T | 22-09-2020 | IPR002293 | Amino acid/polyamine transporter I |
| UnnamedSample_HQ_transcript/6059|m.2561 | UnnamedSample_HQ_transcript/6059 | Coverage 0.969 too low. | 5d3af18f7ab67ec87a947d50e4c687fd | 1014 | Pfam | PF12661 | Human growth factor-like EGF | 242 | 260 | 0.071 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/6059|m.2561 | UnnamedSample_HQ_transcript/6059 | Coverage 0.969 too low. | 5d3af18f7ab67ec87a947d50e4c687fd | 1014 | Pfam | PF12661 | Human growth factor-like EGF | 723 | 742 | 0.0052 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/6059|m.2561 | UnnamedSample_HQ_transcript/6059 | Coverage 0.969 too low. | 5d3af18f7ab67ec87a947d50e4c687fd | 1014 | Pfam | PF12661 | Human growth factor-like EGF | 504 | 523 | 0.021 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/6059|m.2561 | UnnamedSample_HQ_transcript/6059 | Coverage 0.969 too low. | 5d3af18f7ab67ec87a947d50e4c687fd | 1014 | Pfam | PF07974 | EGF-like domain | 591 | 616 | 8.8E-5 | T | 22-09-2020 | IPR013111 | EGF-like domain, extracellular |
| UnnamedSample_HQ_transcript/6059|m.2561 | UnnamedSample_HQ_transcript/6059 | Coverage 0.969 too low. | 5d3af18f7ab67ec87a947d50e4c687fd | 1014 | Pfam | PF00053 | Laminin EGF domain | 545 | 584 | 0.0016 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/6059|m.2561 | UnnamedSample_HQ_transcript/6059 | Coverage 0.969 too low. | 5d3af18f7ab67ec87a947d50e4c687fd | 1014 | Pfam | PF00053 | Laminin EGF domain | 415 | 459 | 2.8E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/6059|m.2561 | UnnamedSample_HQ_transcript/6059 | Coverage 0.969 too low. | 5d3af18f7ab67ec87a947d50e4c687fd | 1014 | Pfam | PF00053 | Laminin EGF domain | 282 | 327 | 0.014 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/8766|m.3440 | UnnamedSample_HQ_transcript/8766 | Coverage 0.812 too low. | 158b1541098c99275ef317d707c7319c | 941 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 848 | 924 | 1.0E-4 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/8766|m.3440 | UnnamedSample_HQ_transcript/8766 | Coverage 0.812 too low. | 158b1541098c99275ef317d707c7319c | 941 | Pfam | PF00041 | Fibronectin type III domain | 89 | 173 | 2.0E-6 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/90321|m.21301 | UnnamedSample_HQ_transcript/90321 | Coverage 0.342 too low. | e17735bff42033a8f4e8d6cfa8c3c798 | 420 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 30 | 420 | 7.4E-59 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/63339|m.16700 | UnnamedSample_HQ_transcript/63339 | Coverage 0.640 too low. | 33b1160d94b29f72f785cc1d1c6752b6 | 312 | Pfam | PF00001 | 7 transmembrane receptor (rhodopsin family) | 52 | 309 | 1.2E-55 | T | 22-09-2020 | IPR017452 | GPCR, rhodopsin-like, 7TM |
| UnnamedSample_HQ_transcript/12425|m.4634 | UnnamedSample_HQ_transcript/12425 | Coverage 0.640 too low. | 69f4cb78cbaa39ad287942fcbe360ce5 | 742 | Pfam | PF00400 | WD domain, G-beta repeat | 550 | 574 | 0.16 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/12425|m.4634 | UnnamedSample_HQ_transcript/12425 | Coverage 0.640 too low. | 69f4cb78cbaa39ad287942fcbe360ce5 | 742 | Pfam | PF00400 | WD domain, G-beta repeat | 452 | 483 | 0.099 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/12425|m.4634 | UnnamedSample_HQ_transcript/12425 | Coverage 0.640 too low. | 69f4cb78cbaa39ad287942fcbe360ce5 | 742 | Pfam | PF00400 | WD domain, G-beta repeat | 580 | 616 | 0.007 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/12425|m.4634 | UnnamedSample_HQ_transcript/12425 | Coverage 0.640 too low. | 69f4cb78cbaa39ad287942fcbe360ce5 | 742 | Pfam | PF03920 | Groucho/TLE N-terminal Q-rich domain | 20 | 143 | 5.1E-65 | T | 22-09-2020 | IPR005617 | Groucho/TLE, N-terminal Q-rich domain |
| UnnamedSample_HQ_transcript/50224|m.14066 | UnnamedSample_HQ_transcript/50224 | Coverage 0.874 too low. | d55ae2cbadd1804a2d5a6d44ba4657fb | 537 | Pfam | PF00083 | Sugar (and other) transporter | 60 | 497 | 5.7E-88 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/45474|m.13027 | UnnamedSample_HQ_transcript/45474 | Coverage 0.827 too low. | d55ae2cbadd1804a2d5a6d44ba4657fb | 537 | Pfam | PF00083 | Sugar (and other) transporter | 60 | 497 | 5.7E-88 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/2611|m.1280 | UnnamedSample_HQ_transcript/2611 | Coverage 0.938 too low. | d55ae2cbadd1804a2d5a6d44ba4657fb | 537 | Pfam | PF00083 | Sugar (and other) transporter | 60 | 497 | 5.7E-88 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/1854|m.1005 | UnnamedSample_HQ_transcript/1854 | Coverage 0.930 too low. | d55ae2cbadd1804a2d5a6d44ba4657fb | 537 | Pfam | PF00083 | Sugar (and other) transporter | 60 | 497 | 5.7E-88 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/7274|m.2948 | UnnamedSample_HQ_transcript/7274 | Coverage 0.937 too low. | d55ae2cbadd1804a2d5a6d44ba4657fb | 537 | Pfam | PF00083 | Sugar (and other) transporter | 60 | 497 | 5.7E-88 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/2801|m.1361 | UnnamedSample_HQ_transcript/2801 | Coverage 0.948 too low. | d55ae2cbadd1804a2d5a6d44ba4657fb | 537 | Pfam | PF00083 | Sugar (and other) transporter | 60 | 497 | 5.7E-88 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/77722|m.19332 | UnnamedSample_HQ_transcript/77722 | Coverage 0.812 too low. | a4c323f34fb7eb7da3750d8935afbd1f | 423 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/78369|m.19439 | UnnamedSample_HQ_transcript/78369 | Coverage 0.732 too low. | 61ee652d1899554420644ab3341515f1 | 310 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 4 | 73 | 2.8E-25 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/83921|m.20328 | UnnamedSample_HQ_transcript/83921 | Coverage 0.793 too low. | 61ee652d1899554420644ab3341515f1 | 310 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 4 | 73 | 2.8E-25 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/98990|m.22492 | UnnamedSample_HQ_transcript/98990 | Coverage 0.147 too low. | 1885d4735955cee88135e536dcf4dfe6 | 254 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 10 | 254 | 2.7E-83 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/22160|m.7472 | UnnamedSample_HQ_transcript/22160 | Identity 0.945 too low. | b514814614798ad616f28fa7bc682acf | 698 | Pfam | PF08416 | Phosphotyrosine-binding domain | 26 | 147 | 1.3E-16 | T | 22-09-2020 | IPR013625 | Tensin/EPS8 phosphotyrosine-binding domain |
| UnnamedSample_HQ_transcript/29274|m.9300 | UnnamedSample_HQ_transcript/29274 | Identity 0.939 too low. | b514814614798ad616f28fa7bc682acf | 698 | Pfam | PF08416 | Phosphotyrosine-binding domain | 26 | 147 | 1.3E-16 | T | 22-09-2020 | IPR013625 | Tensin/EPS8 phosphotyrosine-binding domain |
| UnnamedSample_HQ_transcript/81327|m.19938 | UnnamedSample_HQ_transcript/81327 | Coverage 0.983 too low. | b9561cacb10f82c803627aed492f30a4 | 141 | Pfam | PF05361 | PKC-activated protein phosphatase-1 inhibitor | 41 | 141 | 2.9E-11 | T | 22-09-2020 | IPR008025 | CPI-17 |
| UnnamedSample_HQ_transcript/53773|m.14798 | UnnamedSample_HQ_transcript/53773 | Identity 0.950 too low. | b9561cacb10f82c803627aed492f30a4 | 141 | Pfam | PF05361 | PKC-activated protein phosphatase-1 inhibitor | 41 | 141 | 2.9E-11 | T | 22-09-2020 | IPR008025 | CPI-17 |
| UnnamedSample_HQ_transcript/60279|m.16115 | UnnamedSample_HQ_transcript/60279 | Identity 0.949 too low. | b9561cacb10f82c803627aed492f30a4 | 141 | Pfam | PF05361 | PKC-activated protein phosphatase-1 inhibitor | 41 | 141 | 2.9E-11 | T | 22-09-2020 | IPR008025 | CPI-17 |
| UnnamedSample_HQ_transcript/58269|m.15707 | UnnamedSample_HQ_transcript/58269 | Coverage 0.906 too low. | 88a38a8ae00183a39ec77b6a46ea8487 | 470 | Pfam | PF02008 | CXXC zinc finger domain | 394 | 433 | 1.9E-6 | T | 22-09-2020 | IPR002857 | Zinc finger, CXXC-type |
| UnnamedSample_HQ_transcript/19896|m.6842 | UnnamedSample_HQ_transcript/19896 | Identity 0.792 too low. | c3c6b2ed20c6d2684a7e7e57590b990c | 930 | Pfam | PF01576 | Myosin tail | 442 | 920 | 3.5E-65 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/19896|m.6842 | UnnamedSample_HQ_transcript/19896 | Identity 0.792 too low. | c3c6b2ed20c6d2684a7e7e57590b990c | 930 | Pfam | PF01576 | Myosin tail | 74 | 444 | 5.9E-58 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/37379|m.11247 | UnnamedSample_HQ_transcript/37379 | Coverage 0.834 too low. | 6af610bc5770dd61e477f8bb5b31e319 | 586 | Pfam | PF02770 | Acyl-CoA dehydrogenase, middle domain | 181 | 291 | 1.1E-13 | T | 22-09-2020 | IPR006091 | Acyl-CoA oxidase/dehydrogenase, central domain |
| UnnamedSample_HQ_transcript/23055|m.7704 | UnnamedSample_HQ_transcript/23055 | Coverage 0.799 too low. | 955e7f439d39a2f67aed3a068cf226b8 | 903 | Pfam | PF00089 | Trypsin | 214 | 458 | 4.7E-35 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/23055|m.7704 | UnnamedSample_HQ_transcript/23055 | Coverage 0.799 too low. | 955e7f439d39a2f67aed3a068cf226b8 | 903 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 2 | 39 | 5.8E-10 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/25356|m.8302 | UnnamedSample_HQ_transcript/25356 | Coverage 0.793 too low. | 955e7f439d39a2f67aed3a068cf226b8 | 903 | Pfam | PF00089 | Trypsin | 214 | 458 | 4.7E-35 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/25356|m.8302 | UnnamedSample_HQ_transcript/25356 | Coverage 0.793 too low. | 955e7f439d39a2f67aed3a068cf226b8 | 903 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 2 | 39 | 5.8E-10 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/24686|m.8127 | UnnamedSample_HQ_transcript/24686 | Coverage 0.984 too low. | 88881176bebf316f90c52d9993ec99e3 | 1009 | Pfam | PF12874 | Zinc-finger of C2H2 type | 888 | 907 | 0.079 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/24686|m.8127 | UnnamedSample_HQ_transcript/24686 | Coverage 0.984 too low. | 88881176bebf316f90c52d9993ec99e3 | 1009 | Pfam | PF00096 | Zinc finger, C2H2 type | 972 | 994 | 7.8E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/34829|m.10681 | UnnamedSample_HQ_transcript/34829 | Coverage 0.781 too low. | 661b9be4c9d8370f290a7a7feac796a4 | 505 | Pfam | PF16179 | Rel homology dimerisation domain | 341 | 432 | 8.1E-25 | T | 22-09-2020 | IPR032397 | Rel homology dimerisation domain |
| UnnamedSample_HQ_transcript/34829|m.10681 | UnnamedSample_HQ_transcript/34829 | Coverage 0.781 too low. | 661b9be4c9d8370f290a7a7feac796a4 | 505 | Pfam | PF00554 | Rel homology DNA-binding domain | 174 | 333 | 1.5E-27 | T | 22-09-2020 | IPR011539 | Rel homology domain (RHD), DNA-binding domain |
| UnnamedSample_HQ_transcript/19240|m.6646 | UnnamedSample_HQ_transcript/19240 | Coverage 0.633 too low. | c965e8c2a228f61f87d568928f6dcd63 | 880 | Pfam | PF00784 | MyTH4 domain | 556 | 674 | 1.6E-26 | T | 22-09-2020 | IPR000857 | MyTH4 domain |
| UnnamedSample_HQ_transcript/19240|m.6646 | UnnamedSample_HQ_transcript/19240 | Coverage 0.633 too low. | c965e8c2a228f61f87d568928f6dcd63 | 880 | Pfam | PF00620 | RhoGAP domain | 711 | 847 | 8.0E-30 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/123318|m.25055 | UnnamedSample_HQ_transcript/123318 | Coverage 0.976 too low. | a8160956da533c82f7b1abbf7352086a | 99 | Pfam | PF00135 | Carboxylesterase family | 1 | 86 | 4.3E-13 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/5883|m.2496 | UnnamedSample_HQ_transcript/5883 | Coverage 0.070 too low. | 40aef3e889fd6bd583f6359d5eae6812 | 799 | Pfam | PF12448 | Kinesin associated protein | 312 | 456 | 4.1E-20 | T | 22-09-2020 | IPR022154 | Trafficking kinesin-binding protein, C-terminal |
| UnnamedSample_HQ_transcript/5883|m.2496 | UnnamedSample_HQ_transcript/5883 | Coverage 0.070 too low. | 40aef3e889fd6bd583f6359d5eae6812 | 799 | Pfam | PF04849 | HAP1 N-terminal conserved region | 1 | 237 | 7.1E-65 | T | 22-09-2020 | IPR006933 | HAP1, N-terminal |
| UnnamedSample_HQ_transcript/24285|m.8018 | UnnamedSample_HQ_transcript/24285 | Unmapped. | ffa5c25771328bbbd6edd9106d1583df | 971 | Pfam | PF08762 | CRPV capsid protein like | 673 | 883 | 4.1E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/24550|m.8086 | UnnamedSample_HQ_transcript/24550 | Coverage 0.877 too low. | 00aa819cd7180a557d16bd1932a8f2f8 | 837 | Pfam | PF13927 | Immunoglobulin domain | 425 | 489 | 2.5E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/24550|m.8086 | UnnamedSample_HQ_transcript/24550 | Coverage 0.877 too low. | 00aa819cd7180a557d16bd1932a8f2f8 | 837 | Pfam | PF13927 | Immunoglobulin domain | 26 | 111 | 1.9E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/24550|m.8086 | UnnamedSample_HQ_transcript/24550 | Coverage 0.877 too low. | 00aa819cd7180a557d16bd1932a8f2f8 | 837 | Pfam | PF13927 | Immunoglobulin domain | 220 | 290 | 2.9E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/24550|m.8086 | UnnamedSample_HQ_transcript/24550 | Coverage 0.877 too low. | 00aa819cd7180a557d16bd1932a8f2f8 | 837 | Pfam | PF07679 | Immunoglobulin I-set domain | 131 | 212 | 1.1E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/24550|m.8086 | UnnamedSample_HQ_transcript/24550 | Coverage 0.877 too low. | 00aa819cd7180a557d16bd1932a8f2f8 | 837 | Pfam | PF07679 | Immunoglobulin I-set domain | 313 | 406 | 7.5E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/24550|m.8086 | UnnamedSample_HQ_transcript/24550 | Coverage 0.877 too low. | 00aa819cd7180a557d16bd1932a8f2f8 | 837 | Pfam | PF00041 | Fibronectin type III domain | 625 | 709 | 7.8E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/24550|m.8086 | UnnamedSample_HQ_transcript/24550 | Coverage 0.877 too low. | 00aa819cd7180a557d16bd1932a8f2f8 | 837 | Pfam | PF00041 | Fibronectin type III domain | 508 | 591 | 7.8E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/8508|m.3352 | UnnamedSample_HQ_transcript/8508 | Coverage 0.097 too low. | e0f33510d235e5073786599771ab98ed | 681 | Pfam | PF00005 | ABC transporter | 57 | 206 | 1.7E-29 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/8508|m.3352 | UnnamedSample_HQ_transcript/8508 | Coverage 0.097 too low. | e0f33510d235e5073786599771ab98ed | 681 | Pfam | PF01061 | ABC-2 type transporter | 407 | 614 | 8.0E-39 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/17076|m.6028 | UnnamedSample_HQ_transcript/17076 | Coverage 0.119 too low. | e0f33510d235e5073786599771ab98ed | 681 | Pfam | PF00005 | ABC transporter | 57 | 206 | 1.7E-29 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/17076|m.6028 | UnnamedSample_HQ_transcript/17076 | Coverage 0.119 too low. | e0f33510d235e5073786599771ab98ed | 681 | Pfam | PF01061 | ABC-2 type transporter | 407 | 614 | 8.0E-39 | T | 22-09-2020 | IPR013525 | ABC-2 type transporter |
| UnnamedSample_HQ_transcript/19958|m.6858 | UnnamedSample_HQ_transcript/19958 | Coverage 0.978 too low. | c9696084714ca6a9af539782fdee70fd | 947 | Pfam | PF00350 | Dynamin family | 305 | 483 | 2.3E-38 | T | 22-09-2020 | IPR022812 | Dynamin superfamily |
| UnnamedSample_HQ_transcript/118788|m.24758 | UnnamedSample_HQ_transcript/118788 | Coverage 0.981 too low. | fadd9390f5cc371b89f6f2caf3c25e66 | 132 | Pfam | PF10036 | RNA transcription, translation and transport factor protein | 3 | 131 | 2.5E-45 | T | 22-09-2020 | IPR019265 | RNA transcription, translation and transport factor protein |
| UnnamedSample_HQ_transcript/78483|m.19458 | UnnamedSample_HQ_transcript/78483 | Coverage 0.458 too low. | 3701b82445a7796e91fb4426a94a2a39 | 327 | Pfam | PF01431 | Peptidase family M13 | 119 | 323 | 1.6E-55 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/81781|m.19997 | UnnamedSample_HQ_transcript/81781 | Coverage 0.972 too low. | e4d4b61ce31da93c43a2e494a5601faa | 272 | Pfam | PF02146 | Sir2 family | 3 | 185 | 1.2E-60 | T | 22-09-2020 | IPR003000 | Sirtuin family |
| UnnamedSample_HQ_transcript/26|m.27 | UnnamedSample_HQ_transcript/26 | Unmapped. | a66ba0f19e779be572f27dc04cb40d9e | 2017 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 5 | 263 | 1.1E-5 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/26|m.27 | UnnamedSample_HQ_transcript/26 | Unmapped. | a66ba0f19e779be572f27dc04cb40d9e | 2017 | Pfam | PF13087 | AAA domain | 848 | 1019 | 1.9E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/26|m.27 | UnnamedSample_HQ_transcript/26 | Unmapped. | a66ba0f19e779be572f27dc04cb40d9e | 2017 | Pfam | PF13086 | AAA domain | 665 | 735 | 1.0E-8 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/25514|m.8346 | UnnamedSample_HQ_transcript/25514 | Coverage 0.959 too low. | 99ab1d15e286d86a2b043c7a51f8ab2a | 776 | Pfam | PF00412 | LIM domain | 149 | 204 | 2.6E-13 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/110|m.109 | UnnamedSample_HQ_transcript/110 | Unmapped. | 5b97c8dcd1bd7b1bc4987a5d5db44731 | 1621 | Pfam | PF13086 | AAA domain | 269 | 339 | 7.9E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/110|m.109 | UnnamedSample_HQ_transcript/110 | Unmapped. | 5b97c8dcd1bd7b1bc4987a5d5db44731 | 1621 | Pfam | PF13087 | AAA domain | 452 | 623 | 1.5E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/5967|m.2529 | UnnamedSample_HQ_transcript/5967 | Identity 0.825 too low. | 5fe3b5e74bd25bc5ea11f998f40f7057 | 1516 | Pfam | PF10347 | RNA pol II promoter Fmp27 protein domain | 455 | 586 | 2.5E-29 | T | 22-09-2020 | IPR019441 | FMP27, GFWDK domain |
| UnnamedSample_HQ_transcript/5967|m.2529 | UnnamedSample_HQ_transcript/5967 | Identity 0.825 too low. | 5fe3b5e74bd25bc5ea11f998f40f7057 | 1516 | Pfam | PF10293 | Domain of unknown function (DUF2405) | 284 | 348 | 2.0E-5 | T | 22-09-2020 | IPR019409 | FMP27, domain of unknown function DUF2405 |
| UnnamedSample_HQ_transcript/5967|m.2529 | UnnamedSample_HQ_transcript/5967 | Identity 0.825 too low. | 5fe3b5e74bd25bc5ea11f998f40f7057 | 1516 | Pfam | PF10351 | Golgi-body localisation protein domain | 1156 | 1505 | 6.6E-77 | T | 22-09-2020 | IPR019443 | FMP27, C-terminal |
| UnnamedSample_HQ_transcript/45435|m.13013 | UnnamedSample_HQ_transcript/45435 | Coverage 0.990 too low. | b237333f64c2b1590fc816f810d57921 | 409 | Pfam | PF00180 | Isocitrate/isopropylmalate dehydrogenase | 10 | 377 | 2.6E-75 | T | 22-09-2020 | IPR024084 | Isopropylmalate dehydrogenase-like domain |
| UnnamedSample_HQ_transcript/76303|m.19078 | UnnamedSample_HQ_transcript/76303 | Coverage 0.986 too low. | b237333f64c2b1590fc816f810d57921 | 409 | Pfam | PF00180 | Isocitrate/isopropylmalate dehydrogenase | 10 | 377 | 2.6E-75 | T | 22-09-2020 | IPR024084 | Isopropylmalate dehydrogenase-like domain |
| UnnamedSample_HQ_transcript/21965|m.7420 | UnnamedSample_HQ_transcript/21965 | Coverage 0.954 too low. | 2b8fd1515da6b4997e002c5cd22413c9 | 318 | Pfam | PF00153 | Mitochondrial carrier protein | 132 | 221 | 2.1E-24 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/21965|m.7420 | UnnamedSample_HQ_transcript/21965 | Coverage 0.954 too low. | 2b8fd1515da6b4997e002c5cd22413c9 | 318 | Pfam | PF00153 | Mitochondrial carrier protein | 229 | 313 | 6.2E-21 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/21965|m.7420 | UnnamedSample_HQ_transcript/21965 | Coverage 0.954 too low. | 2b8fd1515da6b4997e002c5cd22413c9 | 318 | Pfam | PF00153 | Mitochondrial carrier protein | 41 | 125 | 8.5E-25 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/23284|m.7756 | UnnamedSample_HQ_transcript/23284 | Coverage 0.955 too low. | 2b8fd1515da6b4997e002c5cd22413c9 | 318 | Pfam | PF00153 | Mitochondrial carrier protein | 132 | 221 | 2.1E-24 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/23284|m.7756 | UnnamedSample_HQ_transcript/23284 | Coverage 0.955 too low. | 2b8fd1515da6b4997e002c5cd22413c9 | 318 | Pfam | PF00153 | Mitochondrial carrier protein | 229 | 313 | 6.2E-21 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/23284|m.7756 | UnnamedSample_HQ_transcript/23284 | Coverage 0.955 too low. | 2b8fd1515da6b4997e002c5cd22413c9 | 318 | Pfam | PF00153 | Mitochondrial carrier protein | 41 | 125 | 8.5E-25 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/19950|m.6856 | UnnamedSample_HQ_transcript/19950 | Coverage 0.955 too low. | 2b8fd1515da6b4997e002c5cd22413c9 | 318 | Pfam | PF00153 | Mitochondrial carrier protein | 132 | 221 | 2.1E-24 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/19950|m.6856 | UnnamedSample_HQ_transcript/19950 | Coverage 0.955 too low. | 2b8fd1515da6b4997e002c5cd22413c9 | 318 | Pfam | PF00153 | Mitochondrial carrier protein | 229 | 313 | 6.2E-21 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/19950|m.6856 | UnnamedSample_HQ_transcript/19950 | Coverage 0.955 too low. | 2b8fd1515da6b4997e002c5cd22413c9 | 318 | Pfam | PF00153 | Mitochondrial carrier protein | 41 | 125 | 8.5E-25 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/54913|m.15029 | UnnamedSample_HQ_transcript/54913 | Coverage 0.930 too low. | 2b8fd1515da6b4997e002c5cd22413c9 | 318 | Pfam | PF00153 | Mitochondrial carrier protein | 132 | 221 | 2.1E-24 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/54913|m.15029 | UnnamedSample_HQ_transcript/54913 | Coverage 0.930 too low. | 2b8fd1515da6b4997e002c5cd22413c9 | 318 | Pfam | PF00153 | Mitochondrial carrier protein | 229 | 313 | 6.2E-21 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/54913|m.15029 | UnnamedSample_HQ_transcript/54913 | Coverage 0.930 too low. | 2b8fd1515da6b4997e002c5cd22413c9 | 318 | Pfam | PF00153 | Mitochondrial carrier protein | 41 | 125 | 8.5E-25 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/64277|m.16905 | UnnamedSample_HQ_transcript/64277 | Coverage 0.922 too low. | 2b8fd1515da6b4997e002c5cd22413c9 | 318 | Pfam | PF00153 | Mitochondrial carrier protein | 132 | 221 | 2.1E-24 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/64277|m.16905 | UnnamedSample_HQ_transcript/64277 | Coverage 0.922 too low. | 2b8fd1515da6b4997e002c5cd22413c9 | 318 | Pfam | PF00153 | Mitochondrial carrier protein | 229 | 313 | 6.2E-21 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/64277|m.16905 | UnnamedSample_HQ_transcript/64277 | Coverage 0.922 too low. | 2b8fd1515da6b4997e002c5cd22413c9 | 318 | Pfam | PF00153 | Mitochondrial carrier protein | 41 | 125 | 8.5E-25 | T | 22-09-2020 | IPR018108 | Mitochondrial substrate/solute carrier |
| UnnamedSample_HQ_transcript/60730|m.16205 | UnnamedSample_HQ_transcript/60730 | Coverage 0.969 too low. | a0fc773ac68f91bc5bb422d61543aeb8 | 652 | Pfam | PF00041 | Fibronectin type III domain | 504 | 587 | 5.5E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/60730|m.16205 | UnnamedSample_HQ_transcript/60730 | Coverage 0.969 too low. | a0fc773ac68f91bc5bb422d61543aeb8 | 652 | Pfam | PF07679 | Immunoglobulin I-set domain | 127 | 208 | 7.9E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/60730|m.16205 | UnnamedSample_HQ_transcript/60730 | Coverage 0.969 too low. | a0fc773ac68f91bc5bb422d61543aeb8 | 652 | Pfam | PF07679 | Immunoglobulin I-set domain | 309 | 402 | 2.6E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/60730|m.16205 | UnnamedSample_HQ_transcript/60730 | Coverage 0.969 too low. | a0fc773ac68f91bc5bb422d61543aeb8 | 652 | Pfam | PF13927 | Immunoglobulin domain | 421 | 485 | 1.8E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/60730|m.16205 | UnnamedSample_HQ_transcript/60730 | Coverage 0.969 too low. | a0fc773ac68f91bc5bb422d61543aeb8 | 652 | Pfam | PF13927 | Immunoglobulin domain | 22 | 107 | 1.3E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/60730|m.16205 | UnnamedSample_HQ_transcript/60730 | Coverage 0.969 too low. | a0fc773ac68f91bc5bb422d61543aeb8 | 652 | Pfam | PF13927 | Immunoglobulin domain | 216 | 286 | 2.1E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/114103|m.24306 | UnnamedSample_HQ_transcript/114103 | Coverage 0.867 too low. | 08b65edce9a592530a7ad2f776ec216f | 114 | Pfam | PF01431 | Peptidase family M13 | 4 | 110 | 1.7E-25 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/121680|m.24973 | UnnamedSample_HQ_transcript/121680 | Coverage 0.837 too low. | 08b65edce9a592530a7ad2f776ec216f | 114 | Pfam | PF01431 | Peptidase family M13 | 4 | 110 | 1.7E-25 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/21699|m.7343 | UnnamedSample_HQ_transcript/21699 | Coverage 0.241 too low. | bdc5cc9ef96cf46ef61a11bc9db15b43 | 717 | Pfam | PF04821 | Timeless protein | 2 | 88 | 1.3E-16 | T | 22-09-2020 | IPR006906 | Timeless, N-terminal |
| UnnamedSample_HQ_transcript/15127|m.5435 | UnnamedSample_HQ_transcript/15127 | Coverage 0.894 too low. | 3878fd2ddea170a33fcb3a1161d09e8f | 751 | Pfam | PF14223 | gag-polypeptide of LTR copia-type | 65 | 207 | 1.1E-6 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/36269|m.10995 | UnnamedSample_HQ_transcript/36269 | Coverage 0.979 too low. | 248baf0cff43f725a3caded5bb466fd4 | 587 | Pfam | PF00096 | Zinc finger, C2H2 type | 440 | 464 | 3.5E-6 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/36269|m.10995 | UnnamedSample_HQ_transcript/36269 | Coverage 0.979 too low. | 248baf0cff43f725a3caded5bb466fd4 | 587 | Pfam | PF00096 | Zinc finger, C2H2 type | 498 | 520 | 0.0022 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/36269|m.10995 | UnnamedSample_HQ_transcript/36269 | Coverage 0.979 too low. | 248baf0cff43f725a3caded5bb466fd4 | 587 | Pfam | PF00096 | Zinc finger, C2H2 type | 470 | 492 | 1.9E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/26889|m.8690 | UnnamedSample_HQ_transcript/26889 | Identity 0.791 too low. | 7033d76b804af19313d327a56afe14d7 | 398 | Pfam | PF00005 | ABC transporter | 166 | 289 | 1.2E-16 | T | 22-09-2020 | IPR003439 | ABC transporter-like |
| UnnamedSample_HQ_transcript/108672|m.23667 | UnnamedSample_HQ_transcript/108672 | Coverage 0.619 too low. | 4d2d79143d832fefea6ec5bced171a14 | 181 | Pfam | PF00271 | Helicase conserved C-terminal domain | 2 | 106 | 7.2E-30 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/115604|m.24454 | UnnamedSample_HQ_transcript/115604 | Coverage 0.581 too low. | 4d2d79143d832fefea6ec5bced171a14 | 181 | Pfam | PF00271 | Helicase conserved C-terminal domain | 2 | 106 | 7.2E-30 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/11139|m.4203 | UnnamedSample_HQ_transcript/11139 | Coverage 0.990 too low. | 96825a566b2745de8b5451e24b1126ce | 1042 | Pfam | PF02373 | JmjC domain, hydroxylase | 864 | 964 | 6.0E-12 | T | 22-09-2020 | IPR003347 | JmjC domain |
| UnnamedSample_HQ_transcript/20631|m.7043 | UnnamedSample_HQ_transcript/20631 | Coverage 0.971 too low. | fee46ea472fad0f5e8586ca90a216d4c | 669 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 481 | 652 | 2.3E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/20631|m.7043 | UnnamedSample_HQ_transcript/20631 | Coverage 0.971 too low. | fee46ea472fad0f5e8586ca90a216d4c | 669 | Pfam | PF00122 | E1-E2 ATPase | 6 | 82 | 5.6E-17 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/20631|m.7043 | UnnamedSample_HQ_transcript/20631 | Coverage 0.971 too low. | fee46ea472fad0f5e8586ca90a216d4c | 669 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 98 | 410 | 7.4E-17 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/54087|m.14853 | UnnamedSample_HQ_transcript/54087 | Coverage 0.833 too low. | 3e8006d9ac5c49b833a23cb5da7723a7 | 429 | Pfam | PF00001 | 7 transmembrane receptor (rhodopsin family) | 75 | 394 | 1.2E-79 | T | 22-09-2020 | IPR017452 | GPCR, rhodopsin-like, 7TM |
| UnnamedSample_HQ_transcript/70549|m.18020 | UnnamedSample_HQ_transcript/70549 | Coverage 0.975 too low. | a83cccb2b03e852a8e44af6490ce72c3 | 321 | Pfam | PF16891 | Serine-threonine protein phosphatase N-terminal domain | 8 | 55 | 1.6E-19 | T | 22-09-2020 | IPR031675 | Serine-threonine protein phosphatase, N-terminal |
| UnnamedSample_HQ_transcript/70549|m.18020 | UnnamedSample_HQ_transcript/70549 | Coverage 0.975 too low. | a83cccb2b03e852a8e44af6490ce72c3 | 321 | Pfam | PF00149 | Calcineurin-like phosphoesterase | 59 | 249 | 1.5E-38 | T | 22-09-2020 | IPR004843 | Calcineurin-like phosphoesterase domain, ApaH type |
| UnnamedSample_HQ_transcript/64733|m.16985 | UnnamedSample_HQ_transcript/64733 | Coverage 0.988 too low. | a83cccb2b03e852a8e44af6490ce72c3 | 321 | Pfam | PF16891 | Serine-threonine protein phosphatase N-terminal domain | 8 | 55 | 1.6E-19 | T | 22-09-2020 | IPR031675 | Serine-threonine protein phosphatase, N-terminal |
| UnnamedSample_HQ_transcript/64733|m.16985 | UnnamedSample_HQ_transcript/64733 | Coverage 0.988 too low. | a83cccb2b03e852a8e44af6490ce72c3 | 321 | Pfam | PF00149 | Calcineurin-like phosphoesterase | 59 | 249 | 1.5E-38 | T | 22-09-2020 | IPR004843 | Calcineurin-like phosphoesterase domain, ApaH type |
| UnnamedSample_HQ_transcript/1500|m.853 | UnnamedSample_HQ_transcript/1500 | Unmapped. | f2a522f3f22bf16a07fa6d2f85cedbd3 | 1890 | Pfam | PF08762 | CRPV capsid protein like | 887 | 1097 | 1.1E-11 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/1500|m.853 | UnnamedSample_HQ_transcript/1500 | Unmapped. | f2a522f3f22bf16a07fa6d2f85cedbd3 | 1890 | Pfam | PF00910 | RNA helicase | 1511 | 1619 | 7.1E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/17331|m.6101 | UnnamedSample_HQ_transcript/17331 | Coverage 0.959 too low. | 36515a325ef91586e5ffa0add37d477a | 573 | Pfam | PF01237 | Oxysterol-binding protein | 192 | 559 | 6.0E-133 | T | 22-09-2020 | IPR000648 | Oxysterol-binding protein |
| UnnamedSample_HQ_transcript/70248|m.17966 | UnnamedSample_HQ_transcript/70248 | Coverage 0.066 too low. | b251250fe593433a3d0c43d4f9bbbcb1 | 559 | Pfam | PF00057 | Low-density lipoprotein receptor domain class A | 81 | 117 | 8.1E-7 | T | 22-09-2020 | IPR002172 | Low-density lipoprotein (LDL) receptor class A repeat |
| UnnamedSample_HQ_transcript/55857|m.15205 | UnnamedSample_HQ_transcript/55857 | Coverage 0.958 too low. | f378c243fbd8fca24b81f3785b6cfc59 | 264 | Pfam | PF03765 | CRAL/TRIO, N-terminal domain | 53 | 95 | 1.1E-7 | T | 22-09-2020 | IPR011074 | CRAL/TRIO, N-terminal domain |
| UnnamedSample_HQ_transcript/55857|m.15205 | UnnamedSample_HQ_transcript/55857 | Coverage 0.958 too low. | f378c243fbd8fca24b81f3785b6cfc59 | 264 | Pfam | PF00650 | CRAL/TRIO domain | 119 | 253 | 6.5E-29 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/11358|m.4275 | UnnamedSample_HQ_transcript/11358 | Unmapped. | f7bf4b5366fb3c53a418a71efa18c07b | 1149 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 783 | 1108 | 1.1E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/85527|m.20573 | UnnamedSample_HQ_transcript/85527 | Coverage 0.639 too low. | 9dacdb16fd83cb56398eb33a7857cbe5 | 370 | Pfam | PF02913 | FAD linked oxidases, C-terminal domain | 123 | 366 | 1.5E-53 | T | 22-09-2020 | IPR004113 | FAD-linked oxidase, C-terminal |
| UnnamedSample_HQ_transcript/85527|m.20573 | UnnamedSample_HQ_transcript/85527 | Coverage 0.639 too low. | 9dacdb16fd83cb56398eb33a7857cbe5 | 370 | Pfam | PF01565 | FAD binding domain | 1 | 86 | 1.0E-17 | T | 22-09-2020 | IPR006094 | FAD linked oxidase, N-terminal |
| UnnamedSample_HQ_transcript/43|m.44 | UnnamedSample_HQ_transcript/43 | Unmapped. | 25d919f56956c95c9caa0b739553cb79 | 1965 | Pfam | PF13086 | AAA domain | 613 | 683 | 9.9E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/43|m.44 | UnnamedSample_HQ_transcript/43 | Unmapped. | 25d919f56956c95c9caa0b739553cb79 | 1965 | Pfam | PF13087 | AAA domain | 796 | 967 | 1.9E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/42|m.43 | UnnamedSample_HQ_transcript/42 | Unmapped. | 25d919f56956c95c9caa0b739553cb79 | 1965 | Pfam | PF13086 | AAA domain | 613 | 683 | 9.9E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/42|m.43 | UnnamedSample_HQ_transcript/42 | Unmapped. | 25d919f56956c95c9caa0b739553cb79 | 1965 | Pfam | PF13087 | AAA domain | 796 | 967 | 1.9E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/22|m.23 | UnnamedSample_HQ_transcript/22 | Unmapped. | 25d919f56956c95c9caa0b739553cb79 | 1965 | Pfam | PF13086 | AAA domain | 613 | 683 | 9.9E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/22|m.23 | UnnamedSample_HQ_transcript/22 | Unmapped. | 25d919f56956c95c9caa0b739553cb79 | 1965 | Pfam | PF13087 | AAA domain | 796 | 967 | 1.9E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/89257|m.21122 | UnnamedSample_HQ_transcript/89257 | Unmapped. | 89fb9f643d2defd485ca3e37398393c6 | 362 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 23 | 343 | 4.2E-54 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/97346|m.22284 | UnnamedSample_HQ_transcript/97346 | Unmapped. | 89fb9f643d2defd485ca3e37398393c6 | 362 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 23 | 343 | 4.2E-54 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/83069|m.20208 | UnnamedSample_HQ_transcript/83069 | Unmapped. | 89fb9f643d2defd485ca3e37398393c6 | 362 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 23 | 343 | 4.2E-54 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/85957|m.20643 | UnnamedSample_HQ_transcript/85957 | Coverage 0.617 too low. | 2950b6aaad73937934582b7416bea718 | 369 | Pfam | PF00041 | Fibronectin type III domain | 239 | 315 | 6.3E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/31351|m.9803 | UnnamedSample_HQ_transcript/31351 | Coverage 0.397 too low. | e16d6685d40d4eb6b59d2f1e5773be39 | 567 | Pfam | PF00581 | Rhodanese-like domain | 409 | 515 | 1.8E-14 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/17967|m.6291 | UnnamedSample_HQ_transcript/17967 | Coverage 0.319 too low. | e16d6685d40d4eb6b59d2f1e5773be39 | 567 | Pfam | PF00581 | Rhodanese-like domain | 409 | 515 | 1.8E-14 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/22238|m.7497 | UnnamedSample_HQ_transcript/22238 | Identity 0.701 too low. | 51293d28d8ab638b891b7484cc9014a9 | 521 | Pfam | PF00625 | Guanylate kinase | 341 | 503 | 8.6E-12 | T | 22-09-2020 | IPR008145 | Guanylate kinase/L-type calcium channel beta subunit |
| UnnamedSample_HQ_transcript/22238|m.7497 | UnnamedSample_HQ_transcript/22238 | Identity 0.701 too low. | 51293d28d8ab638b891b7484cc9014a9 | 521 | Pfam | PF00595 | PDZ domain | 110 | 186 | 6.9E-12 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/51217|m.14283 | UnnamedSample_HQ_transcript/51217 | Unmapped. | e3e15dabd6c634413891ebd2303a0b00 | 522 | Pfam | PF04998 | RNA polymerase Rpb1, domain 5 | 186 | 424 | 9.2E-55 | T | 22-09-2020 | IPR007081 | RNA polymerase Rpb1, domain 5 |
| UnnamedSample_HQ_transcript/51217|m.14283 | UnnamedSample_HQ_transcript/51217 | Unmapped. | e3e15dabd6c634413891ebd2303a0b00 | 522 | Pfam | PF04983 | RNA polymerase Rpb1, domain 3 | 10 | 64 | 8.0E-10 | T | 22-09-2020 | IPR007066 | RNA polymerase Rpb1, domain 3 |
| UnnamedSample_HQ_transcript/51217|m.14283 | UnnamedSample_HQ_transcript/51217 | Unmapped. | e3e15dabd6c634413891ebd2303a0b00 | 522 | Pfam | PF05000 | RNA polymerase Rpb1, domain 4 | 94 | 183 | 1.3E-19 | T | 22-09-2020 | IPR007083 | RNA polymerase Rpb1, domain 4 |
| UnnamedSample_HQ_transcript/76001|m.19021 | UnnamedSample_HQ_transcript/76001 | Coverage 0.956 too low. | 9cd5f5e3655b2d5f1f2493411cca7818 | 441 | Pfam | PF02096 | 60Kd inner membrane protein | 156 | 352 | 1.7E-23 | T | 22-09-2020 | IPR001708 | Membrane insertase YidC/ALB3/OXA1/COX18 |
| UnnamedSample_HQ_transcript/90225|m.21285 | UnnamedSample_HQ_transcript/90225 | Coverage 0.990 too low. | 5da5a5abc03fe178b1cc7c81b3002d41 | 425 | Pfam | PF16898 | C-terminal associated domain of TOPRIM | 7 | 150 | 1.5E-48 | T | 22-09-2020 | IPR031660 | C-terminal associated domain of TOPRIM |
| UnnamedSample_HQ_transcript/90225|m.21285 | UnnamedSample_HQ_transcript/90225 | Coverage 0.990 too low. | 5da5a5abc03fe178b1cc7c81b3002d41 | 425 | Pfam | PF00521 | DNA gyrase/topoisomerase IV, subunit A | 152 | 424 | 1.5E-92 | T | 22-09-2020 | IPR002205 | DNA topoisomerase, type IIA, subunit A/C-terminal |
| UnnamedSample_HQ_transcript/78034|m.19379 | UnnamedSample_HQ_transcript/78034 | Unmapped. | 835ef94013b25f832ae226b6049f7b9f | 436 | Pfam | PF00587 | tRNA synthetase class II core domain (G, H, P, S and T) | 201 | 385 | 8.4E-41 | T | 22-09-2020 | IPR002314 | Aminoacyl-tRNA synthetase, class II (G/ P/ S/T) |
| UnnamedSample_HQ_transcript/34391|m.10573 | UnnamedSample_HQ_transcript/34391 | Coverage 0.969 too low. | be20fd42d437c5b8aae252f190e975a5 | 872 | Pfam | PF00435 | Spectrin repeat | 41 | 139 | 7.7E-7 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/90637|m.21348 | UnnamedSample_HQ_transcript/90637 | Coverage 0.952 too low. | b1c51acfc734d34efd45e5d5e18df7e2 | 230 | Pfam | PF10607 | CTLH/CRA C-terminal to LisH motif domain | 66 | 208 | 2.3E-36 | T | 22-09-2020 | IPR024964 | CTLH/CRA C-terminal to LisH motif domain |
| UnnamedSample_HQ_transcript/90637|m.21348 | UnnamedSample_HQ_transcript/90637 | Coverage 0.952 too low. | b1c51acfc734d34efd45e5d5e18df7e2 | 230 | Pfam | PF08513 | LisH | 29 | 54 | 1.2E-9 | T | 22-09-2020 | IPR006594 | LIS1 homology motif |
| UnnamedSample_HQ_transcript/57769|m.15607 | UnnamedSample_HQ_transcript/57769 | Coverage 0.981 too low. | 42aeac1fcdaaabded7648829fd2fbfb2 | 170 | Pfam | PF00012 | Hsp70 protein | 12 | 168 | 2.1E-42 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/55619|m.15160 | UnnamedSample_HQ_transcript/55619 | Identity 0.880 too low. | 2350c0c8992882d52d5b300edcb80de5 | 493 | Pfam | PF01417 | ENTH domain | 3 | 127 | 1.2E-43 | T | 22-09-2020 | IPR013809 | ENTH domain |
| UnnamedSample_HQ_transcript/961|m.615 | UnnamedSample_HQ_transcript/961 | Coverage 0.217 too low. | 03193765024d71227b9e6da9527c3417 | 1417 | Pfam | PF10541 | Nuclear envelope localisation domain | 1364 | 1417 | 2.6E-17 | T | 22-09-2020 | IPR012315 | KASH domain |
| UnnamedSample_HQ_transcript/15235|m.5479 | UnnamedSample_HQ_transcript/15235 | Coverage 0.497 too low. | 373c73d1c37f2b4b842d0c1104412021 | 743 | Pfam | PF13895 | Immunoglobulin domain | 360 | 434 | 1.9E-12 | T | 22-09-2020 | IPR007110 | Immunoglobulin-like domain |
| UnnamedSample_HQ_transcript/15235|m.5479 | UnnamedSample_HQ_transcript/15235 | Coverage 0.497 too low. | 373c73d1c37f2b4b842d0c1104412021 | 743 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 160 | 234 | 6.0E-5 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/77642|m.19315 | UnnamedSample_HQ_transcript/77642 | Coverage 0.975 too low. | b0c2690d444a8f915ed1eed7d2e2649d | 499 | Pfam | PF07679 | Immunoglobulin I-set domain | 2 | 57 | 3.1E-8 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/77642|m.19315 | UnnamedSample_HQ_transcript/77642 | Coverage 0.975 too low. | b0c2690d444a8f915ed1eed7d2e2649d | 499 | Pfam | PF07679 | Immunoglobulin I-set domain | 158 | 251 | 1.6E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/77642|m.19315 | UnnamedSample_HQ_transcript/77642 | Coverage 0.975 too low. | b0c2690d444a8f915ed1eed7d2e2649d | 499 | Pfam | PF13927 | Immunoglobulin domain | 270 | 334 | 1.2E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/77642|m.19315 | UnnamedSample_HQ_transcript/77642 | Coverage 0.975 too low. | b0c2690d444a8f915ed1eed7d2e2649d | 499 | Pfam | PF13927 | Immunoglobulin domain | 65 | 135 | 1.4E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/77642|m.19315 | UnnamedSample_HQ_transcript/77642 | Coverage 0.975 too low. | b0c2690d444a8f915ed1eed7d2e2649d | 499 | Pfam | PF00041 | Fibronectin type III domain | 353 | 436 | 3.7E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/342|m.266 | UnnamedSample_HQ_transcript/342 | Coverage 0.260 too low. | e3527cd775992fe72ee2b68828a4ed37 | 1205 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 791 | 1188 | 3.1E-44 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/362|m.282 | UnnamedSample_HQ_transcript/362 | Coverage 0.262 too low. | e3527cd775992fe72ee2b68828a4ed37 | 1205 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 791 | 1188 | 3.1E-44 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/442|m.337 | UnnamedSample_HQ_transcript/442 | Coverage 0.242 too low. | e3527cd775992fe72ee2b68828a4ed37 | 1205 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 791 | 1188 | 3.1E-44 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/115321|m.24431 | UnnamedSample_HQ_transcript/115321 | Coverage 0.180 too low. | 8360653fe5020e6f524dcf6ebea06a45 | 109 | Pfam | PF01553 | Acyltransferase | 9 | 83 | 2.6E-5 | T | 22-09-2020 | IPR002123 | Phospholipid/glycerol acyltransferase |
| UnnamedSample_HQ_transcript/60167|m.16094 | UnnamedSample_HQ_transcript/60167 | Coverage 0.705 too low. | 1b2bd5d1e9b53bf328644a1ff15e994b | 438 | Pfam | PF13637 | Ankyrin repeats (many copies) | 1 | 53 | 3.2E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/60167|m.16094 | UnnamedSample_HQ_transcript/60167 | Coverage 0.705 too low. | 1b2bd5d1e9b53bf328644a1ff15e994b | 438 | Pfam | PF00531 | Death domain | 343 | 416 | 6.1E-9 | T | 22-09-2020 | IPR000488 | Death domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
